Norbornene Amphiphilic Compounds for Membrane Protein Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional amphiphilic molecules used for extracting and stabilizing membrane proteins often cause denaturation and aggregation, limiting research on their structure and function due to their simple chemical structure and inability to maintain stability in aqueous solutions.
Innovation Solution
Development of norbornene-based amphiphilic compounds with a norbornene linker and maltoside hydrophilic groups, which form micelles at low concentrations, optimizing the hydrophile-lipophile balance and enhancing the stability and crystallization of membrane proteins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional amphiphilic molecules (OG, NG, DM, DDM, LDAO) are used for membrane protein extraction and stabilization, then membrane proteins can be solubilized in aqueous solutions, but the membrane proteins tend to be easily denatured and aggregated, rapidly losing their function
Solution Approach 1:
The invention modifies the chemical structure parameters of conventional amphiphilic molecules by introducing a norbornene core structure with specific hydrophobic alkyl groups (R1 and R2) and hydrophilic saccharide groups (X1 and X2). This structural parameter change creates compounds with optimized hydrophile-lipophile balance that maintain membrane protein stability without causing denaturation or aggregation, as evidenced by the patent's demonstration of prolonged protein function retention.
Solution Approach 2:
The invention creates composite amphiphilic molecules by combining a norbornene core structure with both hydrophobic alkyl groups and hydrophilic saccharide groups in a single molecule. This composite structure enables the compound to simultaneously interact with both hydrophobic membrane protein regions and aqueous environments, providing superior stabilization compared to conventional single-structure detergents.
2Ease of manufacture
If conventional amphiphilic molecules with simple chemical structures are used, then they are easy to manufacture and use, but they do not exhibit various characteristics and cannot maintain long-term stability
Solution Approach 1:
The invention systematically varies parameters including the length of hydrophobic alkyl groups (R1 and R2 being C3-C30), the type of saccharide groups (X1 and X2 being monosaccharides, disaccharides, or polysaccharides), and the norbornene core configuration to create a series of compounds with different functional characteristics. This parameter optimization enables long-term stability while maintaining reasonable manufacturability.
3Measurement precision
If membrane proteins are extracted and solubilized in aqueous solutions, then structural analysis can be performed, but the proteins rapidly lose their function due to denaturation and aggregation
Solution Approach 1:
The invention applies norbornene-based amphiphilic compounds to membrane proteins during the extraction and solubilization steps before structural analysis is performed. This preliminary stabilization action prevents denaturation and aggregation that would otherwise occur during subsequent handling and analysis procedures, thereby preserving protein function throughout the entire analytical process.
Data Source
AI summary
Provided are a newly developed norbornene-based amphiphilic compound, a method for preparing the same, and a method for extracting, solubilizing, stabilizing, crystallizing or analyzing a membrane protein using the same. In addition, the compound may effectively extract membrane proteins having various structures and characteristics, compared to a conventional compound, from cell membranes, and may be stably stored in an aqueous solution for a long period of time, and therefore may be used in their functional analysis and structural analysis. The structural and functional analyses of membrane proteins are the most noticeable field in biology and chemistry today due to a close relationship to the development of new drugs.